You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bicalutamide

Showing 1 - 25 of 240
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Urothelial Carcinoma Trial in Québec (Bicalutamide 150 mg, Placebo)

Not yet recruiting
  • Metastatic Urothelial Carcinoma
  • Bicalutamide 150 mg
  • Placebo
  • Québec, Canada
    CHU de Québec - Université Laval
Sep 6, 2023

NAFLD, PCOS Trial in San Francisco (Bicalutamide 50 mg, Placebo)

Not yet recruiting
  • NAFLD
  • PCOS
  • Bicalutamide 50 mg
  • Placebo
  • San Francisco, California
    University of California San Francisco
Aug 4, 2023

Breast Tumor Female, Breast Cancer, Breast Carcinoma Trial in Portland (Nivolumab, Ipilimumab, Bicalutamide)

Recruiting
  • Breast Neoplasm Female
  • +3 more
  • New York, New York
  • +1 more
Dec 21, 2022

Metastatic Breast Cancer (MBC) Trial in United States (Palbociclib, Bicalutamide)

Active, not recruiting
  • Metastatic Breast Cancer (MBC)
  • Basking Ridge, New Jersey
  • +4 more
Oct 31, 2022

Non-Muscle Invasive Bladder Cancer Trial in Québec (Bicalutamide, Control Arm)

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • Bicalutamide
  • Control Arm
  • Québec, Canada
    CHU de Québec-Université Laval
Jul 13, 2022

Cancer of Prostate Trial in Bethesda, Philadelphia (Observation and Bicalutamide, Metformin and Bicalutamide)

Completed
Has Results
  • Cancer of Prostate
  • Observation and Bicalutamide
  • Metformin and Bicalutamide
  • Bethesda, Maryland
  • +1 more
Mar 2, 2022

Triple Negative Breast Cancer Trial in United States (ribociclib, Bicalutamide)

Recruiting
  • Triple Negative Breast Cancer
  • Chicago, Illinois
  • +5 more
Oct 31, 2022

Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

Completed
Has Results
  • Breast Cancer
  • bicalutamide
  • +2 more
  • San Francisco, California
  • +7 more
Jul 8, 2022

Covid19, SARS-CoV Infection, Coronavirus Infection Trial in Baltimore (Camostat Mesilate, Bicalutamide 150 mg)

Terminated
  • Covid19
  • +2 more
  • Camostat Mesilate
  • Bicalutamide 150 mg
  • Baltimore, Maryland
    Johns Hopkins Hospital
Sep 15, 2021

Prostate Adenocarcinoma Trial run by the (bicalutamide, Stereotactic body radiation therapy)

Recruiting
  • Prostate Adenocarcinoma
  • bicalutamide
  • Stereotactic body radiation therapy
  • Bethesda, Maryland
    National Cancer Institute
Oct 1, 2021

Breast Cancer, Metastasis Trial in New York (Abemaciclib, Bicalutamide)

Recruiting
  • Breast Cancer
  • Metastasis
  • New York, New York
  • +2 more
Oct 14, 2021

Androgen Deprivation Therapy, Prostate Cancer, Hypertension Trial (Gonadotropin-Releasing Hormone Agonist, Androgen receptor

Not yet recruiting
  • Androgen Deprivation Therapy
  • +4 more
  • Gonadotropin-Releasing Hormone Agonist
  • +2 more
  • (no location specified)
Jan 18, 2023

COVID-19 Trial (Bicalutamide 150 Mg Oral Tablet, Placebo)

Withdrawn
  • COVID-19
  • Bicalutamide 150 Mg Oral Tablet
  • Placebo
  • (no location specified)
Jun 30, 2021

Polycystic Ovary Syndrome, Androgen Excess, Metabolic Disease Trial in Dublin (Bicalutamide 50 mg)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • +2 more
  • Bicalutamide 50 mg
  • Dublin, Ireland
    Royal Collage Of Surgeons
Dec 2, 2022

Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

Recruiting
  • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2023

Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)

Not yet recruiting
  • Salivary Duct Carcinoma
  • Goserelin 10.8 mg
  • +2 more
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Aug 23, 2022

Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)

Completed
  • Prostate Cancer
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Sep 12, 2022

Metastatic Triple Negative Breast Cancer Trial in Guangzhou (TPC, Bicalutamide 150 mg)

Terminated
  • Metastatic Triple Negative Breast Cancer
  • TPC
  • Bicalutamide 150 mg
  • Guangzhou, Guangdong, China
  • +1 more
Jan 26, 2021

Prostate Cancer Trial in Washington, Baltimore (drug, procedure, radiation)

Completed
Has Results
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +2 more
Jul 11, 2022

Recurrent Ovarian Cancer, Signal Transduction Pathway Deregulation, Therapy-Associated Cancer Trial in Netherlands (Letrozole

Not yet recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • Letrozole Oral Product
  • +3 more
  • Eindhoven, Brabant, Netherlands
  • +5 more
Jul 29, 2022

Prostate Cancer Trial in Washington, Baltimore (Leuprolide Acetate, Docetaxel, Bicalutamide)

Active, not recruiting
  • Prostate Cancer
  • Leuprolide Acetate
  • +4 more
  • Washington, District of Columbia
  • +1 more
Mar 29, 2022

Prostate Cancer Trial in United States (Bicalutamide, GnRH Agonist, Radiation Therapy)

Recruiting
  • Prostate Cancer
  • Bicalutamide
  • +3 more
  • Stamford, Connecticut
  • +4 more
May 12, 2022

Castration-resistant Prostate Cancer Trial in Osaka (Enzalutamide, Flutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
Sep 8, 2021

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in Birmingham, Detroit, Columbus

Active, not recruiting
  • Adenocarcinoma of the Prostate
  • +2 more
  • Birmingham, Alabama
  • +3 more
Mar 2, 2021

Prostate Cancer Trial in Brescia (Triptorelin Embonate, Bicalutamide 50 mg)

Recruiting
  • Prostate Cancer
  • Triptorelin Embonate
  • Bicalutamide 50 mg
  • Brescia, BS, Italy
    ASST Spedali Civili of Brescia
Oct 29, 2021